Purdue Pharma Agrees to Pay $270 Million to Oklahoma to Settle Case Involving Deceptive Marketing Practices of Opioid Painkillers Representing 1.2% of the Total Potential State Liability Read more
New Canadian Drug Agency Established to Address Soaring Drug Prices and Gaps in Prescription Drug Coverage Read more
Increased Oversight and Penalties for Drug Misclassifications under the Medicaid Services Investment and Accountability Act of 2019 Read more
REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary — Final Guidance Read more